PhoenixBio Co., Ltd.

TSE:6190 Stock Report

Market Cap: JP¥1.5b

PhoenixBio Dividends and Buybacks

Dividend criteria checks 0/6

PhoenixBio does not have a record of paying a dividend.

Key information

n/a

Dividend yield

n/a

Buyback Yield

Total Shareholder Yieldn/a
Future Dividend Yieldn/a
Dividend Growthn/a
Next dividend pay daten/a
Ex dividend daten/a
Dividend per sharen/a
Payout ration/a

Recent dividend and buyback updates

No updates

Recent updates

Analysis Article • Dec 01

Is PhoenixBio (TSE:6190) Using Too Much Debt?

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
Analysis Article • Aug 05

Is PhoenixBio (TSE:6190) A Risky Investment?

TSE:6190 1 Year Share Price vs Fair Value Explore PhoenixBio's Fair Values from the Community and select yours Some say...
Analysis Article • Apr 07

PhoenixBio Co., Ltd. (TSE:6190) Looks Inexpensive After Falling 33% But Perhaps Not Attractive Enough

PhoenixBio Co., Ltd. ( TSE:6190 ) shareholders won't be pleased to see that the share price has had a very rough month...
Analysis Article • Feb 19

PhoenixBio Co., Ltd.'s (TSE:6190) Shares Bounce 31% But Its Business Still Trails The Industry

PhoenixBio Co., Ltd. ( TSE:6190 ) shareholders would be excited to see that the share price has had a great month...
Analysis Article • Nov 18

PhoenixBio Co., Ltd.'s (TSE:6190) Share Price Is Matching Sentiment Around Its Revenues

With a price-to-sales (or "P/S") ratio of 0.8x PhoenixBio Co., Ltd. ( TSE:6190 ) may be sending bullish signals at the...

Stability and Growth of Payments

Fetching dividends data

Stable Dividend: Insufficient data to determine if 6190's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if 6190's dividend payments have been increasing.

Dividend Yield vs Market

PhoenixBio Dividend Yield vs Market
How does 6190 dividend yield compare to the market?
SegmentDividend Yield
Company (6190)n/a
Market Bottom 25% (JP)1.8%
Market Top 25% (JP)3.9%
Industry Average (Life Sciences)3.9%
Analyst forecast (6190) (up to 3 years)n/a

Notable Dividend: Unable to evaluate 6190's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate 6190's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.

Earnings Payout to Shareholders

Earnings Coverage: Insufficient data to calculate 6190's payout ratio to determine if its dividend payments are covered by earnings.

Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as 6190 has not reported any payouts.

Discover strong dividend paying companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/06/10 21:48
End of Day Share Price 2026/06/10 00:00
Earnings2026/03/31
Annual Earnings2026/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

PhoenixBio Co., Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.